Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2005
11/02/2005EP1591443A1 Pyrazole derivative
11/02/2005EP1590358A1 9-ketospinosyn derivatives
11/02/2005EP1590347A1 Isothiazole derivatives
11/02/2005EP1590346A1 4- {'3-(sulfonylamino) phenyl! '1-(cyclymethyl) piperidin-4-ylidene! methyl} benazmide derivatives as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder
11/02/2005EP1590344A2 Anti-cancer medicaments
11/02/2005EP1590337A1 Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors
11/02/2005EP1590329A1 N-aryl heteroaromatic products, compositions containing same and use thereof
11/02/2005EP1590326A2 Substituted alkyl amido piperidines
11/02/2005EP1507530B1 Diaminothiazoles and use thereof as cdk4 inhibitors
11/02/2005EP1446402B1 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase
11/02/2005EP1383749B1 Arylsulfonamides as antiviral agents
11/02/2005EP1377569B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
11/02/2005EP1246807B1 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
11/02/2005EP1159261B1 Antizyme modulators and their use
11/02/2005EP1045833B1 2,3-substituted indole compounds as cox-2 inhibitors
11/02/2005EP0946531B1 Process for the preparation of thiazole derivatives
11/02/2005CN1692108A Pesticidal heterocycles
11/02/2005CN1692100A 4[piperidin-4-yliden-(3-carbamoylphenyl)methyl]benzamide derivatives and their use for the treatment of pain spinal injuries or gastrointestinal disorders
11/02/2005CN1690051A Novel azoles having an insecticidal action
11/02/2005CN1225471C Compounds with growth hormone releasing properties
11/02/2005CN1225462C New piperazine and piperidine compounds
11/01/2005US6960606 Adamantyl Thiazole Thioureas
11/01/2005US6960605 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
11/01/2005US6960601 Imidazole derivatives; appetite suppressants
11/01/2005US6960599 Dopamine D2 receptor and 5-HT1A antagonists; schizophrenia; cognitive activators; Alzheimer's disease; brain disorders; strokes; antiischemic agents; anxiolytic agents; obsessive compulsive disorder; eating, sleeping and sexual disorders
11/01/2005US6960591 Propane-1,3-dione derivative
11/01/2005US6960578 Glutamate receptor antagonists
11/01/2005US6960575 Thiazine derivatives
10/2005
10/27/2005WO2005101838A2 Piperazinylpiperidine derivatives as chemokine receptor antagonists
10/27/2005WO2005100349A2 Polycyclic pyridines as potassium ion channel modulators
10/27/2005WO2005100348A1 Amorphous ziprasidone hydrochloride
10/27/2005WO2005100344A1 Inhibitors of akt activity
10/27/2005WO2005100338A1 5-morpholinylmethylthiophenyl pharmaceutial compounds as p38 map kinase modulators
10/27/2005WO2005100334A1 Dipeptidyl peptidase-iv inhibitors
10/27/2005WO2005100331A2 Antidiabetic agents
10/27/2005WO2005100303A1 Indene derivatives and process for the preparation thereof
10/27/2005WO2005099709A2 Bicyclic heterocycles useful as serine protease inhibitors
10/27/2005WO2005099673A1 Polycylic thiazoles as potassium ion channel modulators
10/27/2005WO2005099353A2 A novel process for the preparation of linezolid and related compounds
10/27/2005WO2005087725A3 Novel compounds as inhibitors of hepatitis c virus ns3 serine protease
10/27/2005WO2005074642A3 Chemical compounds
10/27/2005WO2005034848A3 Inhibitors of cathepsin s
10/27/2005US20050240035 polymerase inhibitors such as -1-(5-Cyano-pyridin-2-yl)-3-(1,1a,2,7b-tetrahydro-cyclopropa[c]chromene-1-yl)-urea, used as antiviral agents
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050239865 3-Cyano-2-amide-5,6-dihydrothieno[2,3-b]pyridine derivatives, e.g., tert-butyl 3-cyano-2-[(2-ethylbutanoyl)amino]-5,6-dihydrothieno[2,3-b]pyridine-7(4H) carboxylate; the compounds block the action of glucagon at its receptor and decrease the levels of plasma glucose to treat diabetes
10/27/2005US20050239853 New compounds
10/27/2005US20050239852 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/27/2005US20050239851 Substituted benzoxazoles as estrogenic agents
10/27/2005US20050239843 Diaminothiazoles
10/27/2005US20050239841 New compounds
10/27/2005US20050239835 controlling weight gain; 1-(1-amino-2-phenylethylcarbonyl)-4-cyclohexylpiperidine compounds
10/27/2005US20050239829 Novel piperidine compound
10/27/2005US20050239827 N-(4-(2,2-difluoro-benzo(1,3)dioxol-5-ylcarbamoyl)-3-hydroxy-phenyl)-4,6-Bis-((3R,5S)-3,5-diamino-piperidin-1-yl)-(1,3,5)triazine-2-amine for example; Gram-positive and Gram-negative strains; retains potency against common antibiotic resistant strains
10/27/2005US20050239819 4-Oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
10/27/2005US20050239801 Novel compounds
10/27/2005US20050239800 Polycyclic pyrazines as potassium ion channel modulators
10/27/2005US20050239796 tert-butyl4-{(3,4-dimethoxyphenethyl)[2-(1H-indol-3-yl)acetyl]amino}-1-piperidine carboxylate; somatostatin receptors modulator; anticarcinogenic agent; acromegalia, hypophyseal adenomas, endocrine gastroenteropancreatic tumors including carcinoid syndrome; reducing amination of N-substituted piperidone
10/27/2005US20050239790 Substituted hydroxyethylamine aspartyl protease inhibitors
10/27/2005US20050239786 Triazole derivatives as tachykinin receptor antagonists
10/27/2005US20050239777 Quinazoline derivatives and pharmaceutical compositions containing them
10/27/2005US20050239776 Tachykinin receptor antagonists
10/27/2005US20050239771 Respiratory syncytial virus replication inhibitors
10/27/2005US20050239769 Therapeutic compounds for treating dyslipidemic conditions
10/27/2005US20050239713 Novel tubulysin analogues
10/27/2005US20050239096 via unsymmetrical cyanine dyes that are derivatives of thiazole orange, staining solution and select fluorogenic compounds that are characterized as non-genotoxic; low cost
10/27/2005US20050238614 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
10/27/2005DE102004016845A1 Phenylthioessigsäure-Derivate und ihre Verwendung Phenylthioacetic acid derivatives and their use
10/27/2005CA2562242A1 Polycylic thiazoles as potassium ion channel modulators
10/27/2005CA2562235A1 Piperazinylpiperidine derivatives as chemokine receptor antagonists
10/27/2005CA2561311A1 Inhibitors of akt activity
10/27/2005CA2560346A1 Polycyclic pyridines as potassium ion channel modulators
10/26/2005EP1589017A2 12,13-modified epothilone derivatives
10/26/2005EP1589013A2 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
10/26/2005EP1589008A1 A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent
10/26/2005EP1589007A2 5-membered heterocycle derivatives, production thereof and their use as medicaments
10/26/2005EP1589006A1 Oxa- and thiazole derivatives useful as antidiabetics and antidiobesity agents
10/26/2005EP1587804A1 Androgen receptor antagonists
10/26/2005EP1587803A1 Pyrimidine-4,6-dicarboxylic acid diamides for use as selective mmp 13 inhibitors
10/26/2005EP1587800A1 Thiazole derivatives and their use as vap-1 inhibitors
10/26/2005EP1587795A1 N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as cgrp-antagonists for treating a headache
10/26/2005EP1587791A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
10/26/2005EP1587790A2 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
10/26/2005EP1587787A1 Viral polymerase inhibitors
10/26/2005EP1587509A2 Androgen receptor antagonists
10/26/2005EP1427408A4 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE)
10/26/2005EP1289965B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005EP1129071B1 Phenyl-substituted cyclic enaminones
10/26/2005EP0835245B1 Substituted n-methylenethioureas as pesticides
10/26/2005CN1688574A Indole-3-carboxamides as glucokinase(GK) activators
10/26/2005CN1688571A Substituted heterocyclylpyrimidines
10/26/2005CN1688557A Thiazole compounds for treatment of neurodegenerative disorders
10/26/2005CN1688315A Use of selective COX-2 inhibitors for the treatment of urinary incontinence
10/26/2005CN1224623C 1-phenysulfonyl-1, 3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use
10/26/2005CN1224622C Method for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene derivative
10/25/2005US6958401 Method for synthesizing epothilones and epothilone analogs
10/25/2005US6958355 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
10/25/2005US6958350 Chemical compounds
10/25/2005US6958348 Side effect reduction
10/25/2005US6958340 such as N-[3-methyl-5-(trifluoromethyl)phenyl]-4-(2-phenyl-1H-imidazol-1-yl)pyrimidin-2-amine; treating breast cancer; use in combination with estrogen receptor modulators such as tamoxifen and raloxifene
1 ... 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 ... 628